Home/Pipeline/Iohexol (Omnipaque generic)

Iohexol (Omnipaque generic)

Diagnostic Imaging

Pending ApprovalAnticipated Launch Q1 2026

Key Facts

Indication
Diagnostic Imaging
Phase
Pending Approval
Status
Anticipated Launch Q1 2026
Company

About Amneal Pharmaceuticals

Amneal Pharmaceuticals is a publicly traded, integrated biopharmaceutical company with a 20+ year history focused on expanding access to essential medicines. It operates across three core segments: Complex Generics, Biosciences (biosimilars and injectables), and Specialty branded pharmaceuticals, primarily in CNS and endocrine disorders. The company leverages over 1 million square feet of U.S. manufacturing capacity, has a robust pipeline with 69 pending ANDAs, and is led by its founding Patel brothers, aiming to bring manufacturing of critical medicines back to the United States.

View full company profile

Other Diagnostic Imaging Drugs

DrugCompanyPhase
Contrast MediaNipro CorporationCommercial